ADT
33
-4
GOOGL
69
-3
XEL
55
2
PYPL
60
-2
JNJ
33
-2
NKE
40
-2
FLR
48
-4
CI
33
-3
PCAR
50
-6
AIV
71
4
NWS
56
-4
FOX
60
7
DLTR
48
-3
REGN
45
-3
RIG
49
-5
FOXA
63
6
TAP
58
-3
CNP
60
5
CHD
32
-2
DTE
45
-2
ADT
33
-4
GOOGL
69
-3
XEL
55
2
PYPL
60
-2
JNJ
33
-2
NKE
40
-2
FLR
48
-4
CI
33
-3
PCAR
50
-6
AIV
71
4
NWS
56
-4
FOX
60
7
DLTR
48
-3
REGN
45
-3
RIG
49
-5
FOXA
63
6
TAP
58
-3
CNP
60
5
CHD
32
-2
DTE
45
-2
Financhill
Back

Cellectar Biosciences Vs. Revance Therapeutics Industry Stock Comparison

Sell
23

CLRB
Cellectar Biosciences

Last Price:
0.25
Seasonality Move:
-1.67%
Sell
9

RVNC
Revance Therapeutics

Last Price:
3.09
Seasonality Move:
2.04%
Sell
23
Cellectar Biosciences (CLRB) is a Sell

Is Cellectar Biosciences a Buy, Sell or Hold?

  • The current Cellectar Biosciences [CLRB] share price is $0.26. The Score for CLRB is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • CLRB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
9
Revance Therapeutics (RVNC) is a Sell

Is Revance Therapeutics a Buy, Sell or Hold?

  • The current Revance Therapeutics [RVNC] share price is $3.09. The Score for RVNC is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
  • RVNC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CLRB Stock Price Chart

What is Cellectar Biosciences's stock price today?

  • The Cellectar Biosciences share price today is $0.26
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing selling pressure, which indicates risk of future bearish movement.

RVNC Stock Price Chart

What is Revance Therapeutics's stock price today?

  • The Revance Therapeutics share price today is $3.09
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing slight buying pressure.

CLRB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.31 Sell
Relative Strength Index (14 RSI): 5.91 Sell
Chaikin Money Flow: -6267615 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.11 - 2.03) Sell
Bollinger Bands (100): (1.63 - 2.29) Sell

RVNC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.42 Sell
Relative Strength Index (14 RSI): 32.86 Sell
Chaikin Money Flow: 4004349 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.3 - 4.38) Sell
Bollinger Bands (100): (3.85 - 6.27) Sell

CLRB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.11 Sell
20-day SMA: 1.43 Sell
50-day SMA: 1.82 Sell
200-day SMA: 2.6 Sell
8-day EMA: 0.97 Sell
20-day EMA: 1.34 Sell
50-day EMA: 1.69 Sell
200-day EMA: 2.29 Sell

RVNC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.5 Sell
20-day SMA: 3.73 Sell
50-day SMA: 4.63 Sell
200-day SMA: 4.47 Sell
8-day EMA: 3.36 Sell
20-day EMA: 3.77 Sell
50-day EMA: 4.37 Sell
200-day EMA: 5.72 Sell

Cellectar Biosciences Earnings Growth & CLRB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.81 per share.

Revance Therapeutics Earnings Growth & RVNC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.38 per share, and an increase next year of $0.63 per share.

Cellectar Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Revance Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):